Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ella Daly

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Advances in Neurobiology|March 17, 2023
Post-Approval Research in Drug Development: Priorities and PracticesDavid Williamson, Jack Sheehan, Ella Daly
Journal of Thermal Biology|July 9, 2024
The consequences of heatwaves for the reproductive success and physiology of the wingless sub-Antarctic fly Anatalanta apteraElla Daly, Mathilde Defourneaux, Camille Legrand, et al.
Alzheimer Disease and Associated Disorders|March 7, 2003
Psychiatric symptomatology and prodromal Alzheimer's diseaseMaura P Copeland, Ella Daly, Virginia Hines, et al.
The Journal of Clinical Psychiatry|September 16, 2021
Mental Health Care Resource Utilization and Barriers to Receiving Mental Health Services Among US Adults With a Major Depressive Episode and Suicidal Ideation or Behavior With IntentJennifer Voelker, Qian Cai, Ella Daly, et al.
BMC Psychiatry|May 18, 2021
Association of depression symptom severity with short-term risk of an initial hospital encounter in adults with major depressive disorderJennifer Voelker, Kun Wang, Wenze Tang, et al.
Neuropsychiatric Disease and Treatment|May 10, 2011
Number needed to treat and number needed to harm with paliperidone palmitate relative to long-acting haloperidol, bromperidol, and fluphenazine decanoate for treatment of patients with schizophreniaSrihari Gopal, Joris Berwaerts, Isaac Nuamah, et al.
Health and Quality of Life Outcomes|May 9, 2023
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressantCarol Jamieson, Vanina Popova, Ella Daly, et al.
Current Medical Research and Opinion|October 30, 2020
Economic burden of treatment-resistant depression in privately insured US patients with co-occurring anxiety disorder and/or substance use disorderMaryia Zhdanava, Harsh Kuvadia, Kruti Joshi, et al.
Journal of Managed Care & Specialty Pharmacy|June 20, 2020
Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical ConditionsMaryia Zhdanava, Harsh Kuvadia, Kruti Joshi, et al.
Depression and Anxiety|December 8, 2011
What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?Jackie K Gollan, Maurizio Fava, Benji Kurian, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Advances in Neurobiology|March 17, 2023
Post-Approval Research in Drug Development: Priorities and PracticesDavid Williamson, Jack Sheehan, Ella Daly
Journal of Thermal Biology|July 9, 2024
The consequences of heatwaves for the reproductive success and physiology of the wingless sub-Antarctic fly Anatalanta apteraElla Daly, Mathilde Defourneaux, Camille Legrand, et al.
Alzheimer Disease and Associated Disorders|March 7, 2003
Psychiatric symptomatology and prodromal Alzheimer's diseaseMaura P Copeland, Ella Daly, Virginia Hines, et al.
The Journal of Clinical Psychiatry|September 16, 2021
Mental Health Care Resource Utilization and Barriers to Receiving Mental Health Services Among US Adults With a Major Depressive Episode and Suicidal Ideation or Behavior With IntentJennifer Voelker, Qian Cai, Ella Daly, et al.
BMC Psychiatry|May 18, 2021
Association of depression symptom severity with short-term risk of an initial hospital encounter in adults with major depressive disorderJennifer Voelker, Kun Wang, Wenze Tang, et al.
Neuropsychiatric Disease and Treatment|May 10, 2011
Number needed to treat and number needed to harm with paliperidone palmitate relative to long-acting haloperidol, bromperidol, and fluphenazine decanoate for treatment of patients with schizophreniaSrihari Gopal, Joris Berwaerts, Isaac Nuamah, et al.
Health and Quality of Life Outcomes|May 9, 2023
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressantCarol Jamieson, Vanina Popova, Ella Daly, et al.
Current Medical Research and Opinion|October 30, 2020
Economic burden of treatment-resistant depression in privately insured US patients with co-occurring anxiety disorder and/or substance use disorderMaryia Zhdanava, Harsh Kuvadia, Kruti Joshi, et al.
Journal of Managed Care & Specialty Pharmacy|June 20, 2020
Economic Burden of Treatment-Resistant Depression in Privately Insured U.S. Patients with Physical ConditionsMaryia Zhdanava, Harsh Kuvadia, Kruti Joshi, et al.
Depression and Anxiety|December 8, 2011
What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?Jackie K Gollan, Maurizio Fava, Benji Kurian, et al.
Pageof 3